Nine US States Plan Managed Care Act

20 January 1997

A bipartisan group of US state lawmakers has drafted the Managed CareConsumer Protection Act, which sets quality standards for managed care plans in the hope of avoiding what they term "piecemeal" attempts to place consumer standards on the industry.

The bill, to be introduced in New Jersey, Texas, Colorado, Georgia, Delaware, Kansas, Ohio, Oregon and Tennessee, was developed by a panel convened by a nonprofit educational association, Women in Government, which says it aims to strike a balance between patients and business.

The model bill provides safeguards for enrollees on specific issues, eg access to medical specialists, grievance procedures, choice of provider, quality of care based on clinical outcomes, criteria for covering experimental drugs and treatments, and ensuring that licensed doctors not business personnel set treatment policies. It includes no specific mandates on what plans must cover but does set general requirements, some of which run counter to common cost-cutting measures used by managed care companies.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight